Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 59.0 | 53 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 62.0 | 73 | |
N2586 | IL-6 | 100 | ug/mL | 1 | MIP-1B | 75.5 | 76 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 58.5 | 74 | |
N2586 | IGF-I | 100 | ug/mL | 1 | MIP-1B | 63.0 | 63 | ||||
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 63.0 | 55 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 66.0 | 87 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 73.0 | 67 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 70.0 | 55 | |
RA2159 | IGF-I | 100 | ug/mL | 1 | MIP-1B | 61.0 | 68 | ||||
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 61.0 | 84 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 67.0 | 82 | |
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 60.0 | 74 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 66.0 | 75 | |
RA2159 | IL-6 | 100 | ug/mL | 1 | MIP-1B | 77.0 | 51 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 64.5 | 78 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 76.0 | 89 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 67.0 | 74 | |
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 60.5 | 60 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 73.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 62.0 | 65 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MIP-1B | 75.5 | 74 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 62.0 | 61 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 100.0 | 57 | ||||
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | MIP-1B | 62.0 | 63 |